S 3702
115th Congress
Senate
Health
Business records
Civil actions and liability
Home and outpatient care
Inflation and prices
Medicaid
Prescription drugs
State and local government operations
Right Rebate Act of 2018
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 4, 2018
Read twice and referred to the Committee on Finance.
Dec 4, 2018
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Right Rebate Act of 2018
This bill requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).
What's happening now
Read twice and referred to the Committee on Finance.
Related & companion bills
2
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 3702: Right Rebate Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-3702/
"S. 3702: Right Rebate Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-3702/.
S. 3702, 115th Cong. (2026), https://openamerica.io/bill/115-S-3702/.
[S. 3702: Right Rebate Act of 2018](https://openamerica.io/bill/115-S-3702/)